Many assume that because of heavy investment in technology and specialist care, the U.S. health system performs well for patients who have rare or complex diseases. Yet as David Squires and David Blumenthal, M.D., point out in their recent post, new research shows that’s not always true.
Is U.S. Preeminence in High-Tech Medicine a Myth? The Case of Cystic Fibrosis
